Nuvation Bio NUVB Cash Flow Statement (2020-2026)

NYSE NUVB
$4.77 +0.01 (+0.10%)
As of: Oct 21, 2026 · 9:36 AM EDT
Reported Financials

Nuvation Bio Quarterly Cash Flow Statement

Periods 26 quarters
Latest Jun 2026

Nuvation Bio reported cash from operations of -$43.00M and free cash flow of -$43.25M for the quarter ended Jun 2026, up 10.7% year over year. This cash flow statement covers 26 quarters of results from Mar 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow StatementCash Flow Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income
-21.98M-25.13M-21.29M-34.86M-27.20M-20.85M-21.73M-20.64M-19.65M-13.79M-14.79M-462.49M-41.21M-49.45M-53.24M-59.01M-55.79M-36.59M5.40M-62.84M
Depreciation, Depletion & Amortization
Amortization of Deferred ChargesAmort. Deferred Charges
0.02M0.21M0.33M0.32M0.35M
Depreciation & Amortization (CF)Dep. & Amort.
0.07M0.06M0.05M0.05M0.06M0.05M0.06M0.06M0.06M0.06M0.06M0.24M0.16M0.22M0.31M0.36M0.53M0.54M0.54M0.54M
Share-based CompensationStock Comp.
2.75M2.80M3.58M4.79M2.94M4.99M4.84M5.52M5.43M3.72M5.04M9.57M7.48M10.19M7.85M12.03M8.02M7.99M9.03M10.46M
Gains from Sales and DivestituresGains Divest
-0.03M-0.02M-0.01M-0.01M0.01M-0.17M0.17M-0.03M
Gains from Investment SecuritiesGains Investment
-0.37M1.09M-0.21M-0.69M-0.19M-0.13M-0.10M-0.10M0.01M0.04M0.00M-0.01M-0.01M0.01M0.00M0.00M0.00M0.01M0.01M
Other non-cash itemsOther Non-Cash
-0.13M-5.34M-6.32M-3.08M-0.46M0.16M-0.16M0.27M-0.38M2.99M-1.40M423.94M-0.53M-0.57M-0.31M-0.45M-0.61M-0.74M-3.79M9.47M
Change in Working Capital
Change in ReceivablesChange Receivables
0.12M-0.01M12.61M-12.31M2.28M5.63M7.75M6.65M5.10M
Change in InventoryChange Inventory
0.01M0.54M5.16M5.70M4.43M4.06M
Change in Account PayablesChange Payables
0.64M-1.17M5.75M3.06M-9.73M-0.86M0.81M-0.37M-0.20M-0.16M0.23M-3.02M7.17M-6.03M4.19M11.88M-7.06M-5.88M12.96M-9.85M
Change in Accured ExpensesChange Accured Exp.
2.61M3.99M-5.02M0.48M2.31M-0.10M-1.45M1.19M2.30M-2.06M1.51M-5.53M3.53M7.33M-8.94M0.11M8.58M12.60M-12.32M13.77M
Change in Other Operating AssetsOther Assets Change
-1.46M-4.20M4.20M-0.04M-2.70M-1.28M-0.14M-0.15M0.03M-1.46M5.77M-3.55M5.01M1.81M1.00M7.84M-6.49M2.76M0.65M-2.11M
Change in Other Operating LiabilitiesOther Liabilities Change
-0.02M-0.16M0.00M
Other Working Capital ChangesOther WC Changes
1.44M4.05M-4.20M0.04M2.70M1.28M0.14M0.15M-1.39M-0.48M5.81M-2.31M-2.20M-4.33M0.97M-0.43M-1.31M
Cash from OperationsCash from Ops.
-13.15M-23.48M-24.93M-26.92M-28.09M-16.17M-19.33M-17.49M-16.16M-15.03M-15.70M-37.32M-31.09M-46.30M-42.63M-48.18M-52.90M-29.73M5.10M-43.00M
Investing Activities
Capital ExpendituresCapex
0.03M0.14M0.01M0.20M0.10M0.07M0.01M0.02M0.02M0.01M0.03M0.15M-0.01M0.07M0.18M8.01M0.09M0.05M0.25M
Sales of Property, Plant and EquipmentPP&E (Sale)
0.01M0.01M
Change in Property, Plant and EquipmentChange in PP&E
-0.03M-0.14M-0.01M-0.20M-0.10M-0.06M-0.01M-0.02M-0.02M0.00M-0.03M-0.15M0.01M-0.07M-0.18M-8.01M-0.09M-0.05M-0.25M
Acquisitions
0.00M
Net of Acquisitions & DivestmentsNet Acquisitions
0.00M
Purchase of InvestmentsInvestments Purchased
123.18M254.45M131.67M131.00M119.93M137.71M236.97M206.83M110.84M148.74M128.41M93.53M85.66M32.04M60.71M81.67M167.14M44.90M82.15M67.69M
Sale and Maturity of InvestmentsInvestments Sold
31.48M65.32M126.13M157.83M184.23M115.94M184.98M244.20M101.27M181.90M135.98M115.28M114.93M83.89M114.96M136.73M78.53M132.07M38.56M73.94M
Cash from Investing ActivitiesCash from Investing
-91.72M-189.26M-5.55M-15.53M106.37M-21.83M-52.00M37.35M-9.59M33.16M7.54M34.27M29.12M51.77M54.18M54.88M-96.62M87.08M-43.64M5.99M
Financing Activities
Debt Issuance and Repayment
Long-Term Debt IssuancesLT Debt Issuance
Non-Current Debt
Short-Term Debt issuancesST Debt Issuance
5.57M11.20M
Current Debt
5.57M11.20M
Net Debt Issuances and RepaymentsNet Debt Issuance
5.57M11.20M
Change in Capital Stock
Common Stock IssuedStock Issued
0.03M0.23M0.31M0.06M0.26M0.31M0.30M-0.13M0.08M-0.12M0.02M1.82M1.67M0.52M1.08M0.23M0.56M6.93M0.91M2.25M
Net Shares Issued and RepurchasedNet Shares Issued
0.03M0.23M0.31M0.06M0.26M0.31M0.30M-0.13M0.08M-0.12M0.02M1.82M1.67M0.52M1.08M0.23M0.56M6.93M0.91M2.25M
Net Equity Issued and RepurchasedNet Equity Issued
0.03M0.23M0.31M0.06M0.26M0.31M0.30M-0.13M0.08M-0.12M0.02M1.82M1.67M0.52M1.08M0.23M0.56M6.93M0.91M2.25M
Other financing activitiesOther financing
-6.32M-3.21M-7.63M-0.53M-6.77M0.01M-11.20M-10.46M
Cash from Financing ActivitiesCash from Financing
-0.03M0.54M4.26M-3.60M0.26M0.41M0.30M0.13M0.08M0.12M0.02M2.75M-1.54M-0.90M0.55M193.42M0.50M8.06M0.04M170.53M
Additional items
Exchange Rate EffectFX Effect
0.08M-0.74M1.12M0.15M-0.13M-0.06M-0.22M-0.17M-0.34M
Change in Cash
-104.90M-212.21M-26.22M-3.89M36.37M-37.59M-71.03M19.99M-25.67M18.25M-8.14M-0.23M-4.25M5.69M12.25M199.99M-149.07M65.19M-38.70M133.21M
Ending Cash Balance
344.63M132.42M106.21M102.32M138.69M101.10M30.07M50.07M24.40M42.65M34.51M34.29M30.04M35.72M47.98M247.97M98.90M164.09M125.39M258.60M
Free Cash FlowFCF
-13.18M-23.62M-24.94M-27.11M-28.20M-16.23M-19.34M-17.51M-16.18M-15.04M-15.73M-37.32M-31.23M-46.29M-42.70M-48.36M-60.91M-29.82M5.05M-43.25M
Net Cash FlowNCF
-104.90M-212.21M-26.22M-46.05M78.54M-37.59M-71.03M19.99M-25.67M18.25M-8.14M-0.30M-3.51M4.57M12.10M200.12M-149.02M65.42M-38.49M133.52M

Nuvation Bio Cash Flow Statement API

Pull Nuvation Bio's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=NUVB&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY